Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Asset Writedowns and Impairment (2024 - 2025)

Historic Asset Writedowns and Impairment for Fennec Pharmaceuticals (FENC) over the last 5 years, with Q3 2025 value amounting to -$1.7 million.

  • Fennec Pharmaceuticals' Asset Writedowns and Impairment changed N/A to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$318000.0, marking a year-over-year change of. This contributed to the annual value of $3.8 million for FY2024, which is N/A changed from last year.
  • Fennec Pharmaceuticals' Asset Writedowns and Impairment amounted to -$1.7 million in Q3 2025.
  • In the past 5 years, Fennec Pharmaceuticals' Asset Writedowns and Impairment registered a high of $1.1 million during Q2 2025, and its lowest value of -$1.7 million during Q3 2025.